Eli Hurvitz assumed the role of chief executive officer at Teva Pharmaceutical Industries in 1976, overseeing the firm's growth through a series of corporate consolidations. His career in the Israeli industrial sector spanned several decades, during which he influenced national economic policy, managed major banking institutions, and led research organizations until his passing in 2011.
Early Life and Service
Born in Jerusalem in 1932, Hurvitz relocated to Tel Aviv with his family in 1934. In May 1948, he joined the Israel Defense Forces to serve during the Arab-Israeli War. Following his military service, he completed his matriculation exams and briefly resided at kibbutz Tel Katzir. He married Dalia Solomon in June 1953, departing the kibbutz shortly thereafter to pursue higher education in economics at the Hebrew University of Jerusalem.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Ascension at Teva
Hurvitz began his pharmaceutical career at Assia Chemical Labs Ltd., starting in a laboratory role before transitioning to executive positions. Following his 1957 graduation, he remained with the company through its 1964 merger with Zori. By 1969, the entity secured a controlling interest in Teva, and in 1976, the combined firms formed Teva Pharmaceutical Industries Ltd. Hurvitz served as CEO until 2002, when he transitioned to the role of chairman of the board.
Public Service and Economic Policy
Beyond his corporate responsibilities, Hurvitz held numerous public roles, including chairman of the Israel Export Institute between 1974 and 1978 and president of the Israel Manufacturers Association from 1981 to 1986. He directed economic initiatives for Shimon Peres during the mid-1980s to combat inflation. In 1986, he became chairman of Bank Leumi but resigned in 1987 following his association with the 1983 bank stock crisis.
Governance and Legal Challenges
His administrative portfolio included chairing the Jerusalem Development Authority from 1989 to 1992 and the Weizmann Institute of Science executive committee from 1989 to 1995. In 1996, Hurvitz faced legal proceedings regarding alleged tax evasion at a Teva subsidiary, Promedico. Although convicted by the Jerusalem district court in 1998, the Supreme Court of Israel acquitted him in 2000. He later served as chair of the Israel Democracy Institute beginning in 2002.
Fast facts
- Born: 1932, Jerusalem
- Died: 2011, Ramat Gan
- Education: Hebrew University of Jerusalem
- Primary Role: CEO and Chairman, Teva Pharmaceutical Industries
- Israel Prize: 2002
- Citizenship: Israel
Questions readers ask
What major industrial firm did Eli Hurvitz lead?
He served as the CEO and later the chairman of the board for Teva Pharmaceutical Industries.
Did he receive official recognition for his contributions to Israel?
Yes, he was awarded the Israel Prize in 2002 for his lifetime achievement and special contribution to society and the state.
Achievements
- Israel Prize — 2002
- Educated at Hebrew University of Jerusalem
